Skip to main content

Table 1 Affinity measurements using LOCI assay.

From: Functional recombinant MHC class II molecules and high-throughput peptide-binding assays

  

DR1GrpEa

Kompb

DR2a

Kompb

DR2a pH6

DR3

DR4

DRB1*0813

DRB3*0301

DQA1*0501 DQB1*0201

DP401

I-ED

Reference

Designation

Sequence

IC50

(nM)

IC50

(nM)

nM

nM

nM

nM

nM

nM

nM

nM

 

MBP

FLYGALLLA

3921

NB

NB

NB

NB

NB

N.D

N.D

34

NB

[26]

TERT572Y

YLFFYRKSV

4287

NB

2648

NB

1593

95

N.D

N.D

NB

322

 

Flu PR8 derived

FMYSDFHFI

642

1018

637

NB

1130

NB

N.D

N.D

1

NB

[27]

Pox.o42.con A2

FLIDLAFLI

NB

4276

NB

NB

NB

NB

NB

NB

179

NB

 

Pox.o42.con.im. A2

RMIAISAKV

1464

1985

1647

516

NB

267

1259

NB

NB

NB

 

Brucella

WMARRHAER

NB

NB

NB

NB

NB

224

NB

NB

NB

6

 

Salmonella

MMAWRMMRY

7

25

18

1709

68

28

1426

4318

NB

837

 

Flu HA1194-202

IVFMWAIHH

42

529

167

NB

NB

276

NB

NB

NB

NB

 

Hantaan

FMSRKLHRY

NB

2552

NB

279

NB

21

 

NB

NB

3

 

Oxytocinase271

YEKKYFAATQFEPLAARL

5

29

6

38

6

38

33

1090

1

NB

[79] (DP401)

Thyroid peroxidase

YIDVWLGGLAENFLPY

605

691

2138

NB

NB

NB

3184

564

602

NB

[6]

No nat. source

YPFIEQEGPEFFDQE

1279

NB

NB

289

3972

NB

3228

648

NB

NB

[6]

Hepatitis B

YLCQVFADATPTGWGL

1850

NB

3703

69

18

2988

2058

1335

13

NB

[6] (DR3, DR4)

Plasmodium Falciparum

YILLKKILSSRFNQM

7

2

4

32

94

4

1

NB

1

20

[28](DR1, DR2a, DR4)

No natural source

YILFLVKMNALRRLPV

10

20

5

39

?

78

3

NB

45

582

[28] (DR1, DR2a, DR4)

Hepatitis B

VGNFTGLYSSTVPVF

3

31

102

1414

632

2892

9

635

NB

NB

 

Influenza

PLKAEIAQRLEDV

50

41

65

134

2678

NB

11

NB

2091

NB

[29] (DR1, DR2a)

HIV

PIVQNIQGQMVHQ

71

852

447

471

NB

NB

23

NB

NB

NB

[30](DR1)

HepatitisB

PDRVHFASPLHVAWR

5

26

8

6

881

39

3

2807

124

NB

 

Clostridium tetanus

QYIKANSKFIGITE

18

11

22

30

432

29

1

NB

56

1501

[29] (DR1, DR2a)

No nat. source

KILEPFRKYTAFTIP

10

1

16

18

1600

11

1015

1542

30

2198

[34] (DR2a)

Hepatitis B

AFSYMDDVVLGAKSV

215

3382

1721

87

26

2753

764

2039

NB

NB

 

Mycobact leprea

GVTYEIDLTNKN

NB

NB

NB

4346

2548

NB

NB

NB

NB

NB

[6] (DR4)

Murine β2m

IQMLKNGKKIPKVEMS

1232

3

6

21

NB

73

70

NB

NB

117

[31] (I-Ed)

Lambda repressor

YLEDARRLKAIYEKKK

2999

34

87

1098

3120

136

NB

NB

NB

184

[31] (I-Ed)

6xH Lambda 2(315)

HHHHHHIEGRFAALWFRNHFVFGGGTK

4

20

5

882

11

8

1198

NB

2

26

[32]

6xH Influenza A (PR8) HA 109–119

YHHHHHHIEGRSFERFEIFPKE

325

23

9

1429

1869

181

1528

3913

1

984

[33]

CLIP 6xH

LPKPPKPVSKMRMATPLLMQALPMYHHHHHH

1

1

1

1

1

2

1

224

1

23

 

CLIP

YLPKPPKPVSKMRMATPLLMQALPM

1

1

1

1

2

2

1

381

4

72

 

HA306-318

YKYVKQNTLKLAT

7

2

10

13

8

11

4

NB

NB

25

Most DR

  1. Values represent an average of 2–4 measurements. Affinity measurements higher than 5000 nM were categorized as non-binders (NB). N.D: Not determined. a: The DR1 allele used for these measurements was produced as a construct comprising amino acids 1–181 and 1–190 of α and β chain respectively fused C terminally to the dimerizing nucleotide exchange factor GrpE (see additional file 1), this construct was not biotinylated and used in the LOCI competition assay. b: Determined using competitive LOCI assay. The reference column also states the MHC alleles known to bind the peptide.